Expertise and money to increase the impact of your company
This is how we work together for a better world

Nextkidney
The Neokidney™ is a portable device for hemodialysis at home and while traveling, the size of a carry-on suitcase. The device was developed to better align dialysis without a large water purification system or high-voltage power supply with patients' daily routines. This offers more freedom and flexibility than dialysis in a center or with current home equipment, which takes up a lot of space and requires modifications to the home.
_edited.jpg)
2021

Start collaboration
Without dialysis, a kidney patient with kidney failure has no chance of survival. Unfortunately, dialysis at a center or hospital is intensive and time-consuming; it often involves dialyzing for four hours three times a week, sometimes far from where you live. Home hemodialysis offers more flexibility regarding timing, frequency, and duration, but it currently requires significant modifications to your home. Moreover, current home hemodialysis machines take up a lot of space and are noisy, which can be a problem, particularly during nighttime dialysis. Nextkidney is therefore developing the Neokidney™, a compact and portable hemodialysis solution designed to give people with kidney failure more freedom and control over their daily lives. The Neokidney is suitable for short, frequent hemodialysis sessions: 5-6 times a week for 2-3 hours, weighs 10 kg, and can be carried in airplane carry-on luggage. Nextkidney came into contact with Generous Minds through Njord Pattiasina. The first request focused on raising capital and connecting Nextkidney with a broader network of impact investors. From that initial request emerged a long-term partnership in which Generous Minds deploys both Minds and Money to bring the Neokidney to kidney patients' homes.
2022

Brand and positioning
To present Nextkidney's complex medical innovation in a powerful and understandable way, Minds supported the further development of the brand under the guidance of Sabine Beuk. TodayTomorrow contributed to brand design and the website, and we produced a new brand video. This resulted in a stronger story for patients, partners, and investors, with one clear ambition at its core: to align dialysis with patients' lives, rather than the other way around.

2022

€4.2 million crowdfunding
Generous Minds supported Nextkidney in the preparation and execution of a crowdfunding round via Oneplanetcrowd (now Invesdor). Our partner MCPR provided PR support for the campaign, resulting in over 20 publications, including several newspapers. Njord Pattiasina and Ronald Beuk supported the campaign by bringing it to the attention of our Generous Money network. Sabine Beuk guided the crowdfunding round as campaign manager.
The campaign raised €4.2 million, Oneplanetcrowd's largest campaign at the time. With this, Nextkidney not only received new capital for the further development of the Neokidney™, but also engaged a broad group of 1,400+ investors in the company's mission. A wonderful milestone!
"What makes this collaboration special to me is their way of working: persistent, proactive, resourceful, and always in close cooperation with us. Ultimately, we work from the same goal: giving kidney patients more freedom to dialyze wherever and whenever they want.”
– Tom Oostrom, Director of the Kidney Foundation

2023 - 2026

From crowdfunding to growth financing
After the crowdfunding, Generous Minds remained involved in Nextkidney's financing strategy. Ronald Beuk and other Minds helped bring together various types of investors and financiers around the company. In 2026, Nextkidney raised over €20 million in a Series C financing round, with support from Generous Minds, among others.
In addition, Nextkidney reached a significant clinical milestone in 2026: 500 hemodialysis treatments with the Neokidney™ were successfully performed in a European study, including at the UMCs Leiden and Utrecht. The first commercial introduction for use in clinical settings is planned for late 2027, subject to the necessary regulatory approvals.
" I have already dreamed about what my life would be like with the Neokidney. Above all, the feeling of freedom and no longer being tied to home and the hospital enhances the quality of my life. The device is very easy to use and ensures that I regain control. " – Kidney patient Janneke Bresser
As of November 10, a second crowdfunding campaign is live via Invesdor, Europe's largest crowdfunding platform. This is the last opportunity to invest before the commercial market launch in 2027.
